After the FDA nixed its approval for Ampligen and saddled its producer, Hemispherx Biopharma, with paying for a large new trial, it looked like Ampligen was dead and gone.
Francis Collin’s promise to increase ME/CFS funding, however, caused a seismic shift in the drugs outlook. Hemispherx Biopharma’s board quickly fired its controversial, longtime CEO, William Carter, and appointed Thomas Equels to the post.
In an interview Equels said he had one and only one priority: get FDA approval for Ampligen. Find out more in a Simmaron Research Foundation sponsored post:
Health Rising’s Quickie Summer Donation Drive is On!
Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can.
Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000.
Health Rising’s Quickie Summer Donation Drive is On!
Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can.
Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000.
“In 2011 Hemispherx joined with a biotech company called Chronix to develop a diagnostic test for ME/CFS using gene analysis methods it believes will also be able to highlight patients who do well on Ampligen.”
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.
After the FDA nixed its approval for Ampligen and saddled its producer, Hemispherx Biopharma, with paying for a large new trial, it looked like Ampligen was dead and gone.
Health Rising’s Quickie Summer Donation Drive is On!
“In 2011 Hemispherx joined with a biotech company called Chronix to develop a diagnostic test for ME/CFS using gene analysis methods it believes will also be able to highlight patients who do well on Ampligen.”
Is there any recent info on this?
(Tried to put comment on Simmaron site but it wouldn’t take my name & email.)